Company: KAVL
Filing Date: 2025-08-04
Form Type: S-3/A
Source: 0001731122-25-001067
Chunk: 35

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-08-04
Form: S-3/A
Chunk 35
---
 following provisions will apply to any warrants we issue pursuant to this prospectus. In the case of warrants to purchase
common stock, the exercise price payable and the number of shares of common stock purchasable upon warrant exercise may be adjusted in
certain events, including:

| ● | the                                                                                                                    
 issuance of a stock dividend to common stockholders or a combination, subdivision or reclassification of common stock; |

| ● | the                                                                                                                                       
 issuance of rights, warrants or options to all common and preferred stockholders entitling them to purchase common stock for an aggregate 
 consideration per share less than the current market price per share of common stock;                                                     |

| ● | any                                                                                                                                    
 distribution to our common stockholders of evidences of our indebtedness of assets, excluding cash dividends or distributions referred 
 to above; and                                                                                                                          |

| ● | any                                                  
 other events mentioned in the prospectus supplement. |

The prospectus supplement will describe which, if
any, of these provisions shall apply to a particular series of warrants.

Unless otherwise specified in the applicable prospectus
supplement, no adjustment in the number of shares purchasable upon warrant exercise will be required until cumulative adjustments require
an adjustment of at least 1% of such number and no fractional shares will be issued upon warrant exercise, but we will pay the cash value
of any fractional shares otherwise issuable.

Modification

Unless otherwise provided in the applicable prospectus
supplement, the following provisions will apply to any warrants we issue pursuant to this prospectus. We and any agent for any series
of warrants may amend any warrant or rights agreement and the terms of the related warrants by executing a supplemental agreement, without
any such warrant holders’ consent, for the purpose of:

| ● | curing any ambiguity, any defective or inconsistent provision contained in the agreement, or making any other corrections to the agreement that are not inconsistent with the provisions of the warrant certificates; |

| ● | evidencing the succession of another corporation to us and its assumption of our covenants contained in the agreement and the securities; |

| ● | appointing a successor depository if the securities are issued in the form of global securities; |

| ● | evidencing a successor agent’s acceptance of appointment with respect to any securities; |

| ● | adding to our covenants for the benefit of securityholders or surrendering any right or power we have under the agreement; |

| ● | issuing warrants in definitive form, if such securities are initially issued in the form of global